Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Waste Data Preview
In 2023, Teva Pharmaceutical Industries conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
Insights into Teva Pharmaceutical Industries's Waste Treatment Practices
In 2023, Teva Pharmaceutical Industries generated a total of 106,387 metric tonnes of waste.
Of this amount, 41.65% of Teva Pharmaceutical Industries's total waste generated was recovered through methods such as recycling, reuse, or composting, while 58.35% was disposed of through landfilling, incineration, or combustion.
Teva Pharmaceutical Industries's Waste Recovery Rate
How much of Teva Pharmaceutical Industries's waste is recycled or recovered?
In 2023, Teva Pharmaceutical Industries reported a total waste generation of 106,387 metric tonnes, of which 41.65% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that Teva Pharmaceutical Industries is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.
Has Teva Pharmaceutical Industries reduced its environmental waste footprint over time?
Since 2021, Teva Pharmaceutical Industries's total waste generation decreased by 29.41%, including a further 4.32% drop in 2023, highlighting a consistent and deliberate reduction in waste production over time.
Over the same period, Teva Pharmaceutical Industries's waste recovery rate increased by 7.81%, but declined by 5.46% in 2023, potentially signaling volatility in waste treatment processes or shifting priorities in waste management.
Overall, Teva Pharmaceutical Industries’s waste generation and recovery data show a mixed and inconsistent trend. A deeper analysis of the company's activities, industry benchmarks, and operational changes is needed to assess its sustainability performance more precisely.
Teva Pharmaceutical Industries’s Waste Recovery vs. Disposal Over Time
- Total Waste Disposed
- Total Waste Recovered
Insights into Teva Pharmaceutical Industries’s Generation of Hazardous and Non-Hazardous Waste
In 2023, Teva Pharmaceutical Industries generated a total of 106,387 metric tonnes of waste.
Of this amount, 57.86% of Teva Pharmaceutical Industries's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 42.14% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Teva Pharmaceutical Industries’s Hazardous vs Non-Hazardous Waste Over Time
- Total Non-Hazardous Waste Generated
- Total Hazardous Waste Generated
How Teva Pharmaceutical Industries reduced the environmental impact of its waste?
Since 2021, Teva Pharmaceutical Industries's total waste generation decreased by 29.41%, with an additional 4.32% decline in 2023, suggesting a consistent and deliberate effort to minimize waste generation at the source.
Over the same period, Teva Pharmaceutical Industries maintained relatively stable levels of hazardous waste in the long run, but saw a 6.21% drop in 2023, potentially signaling the beginning of a positive downward trend.
Overall, Teva Pharmaceutical Industries's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.
How does Teva Pharmaceutical Industries treat its hazardous waste?
In 2023, Teva Pharmaceutical Industries reported that 61,552 metric tonnes of its total waste output were classified as hazardous. This represents 57.86% of its overall waste generation.
The company treated this hazardous waste using a combination of methods. Approximately 32.71% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.